FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yoko Fujita-Yamaguchi

Research Profile

Chemicals & Drugs

Anatomy

Placenta

Phenomena

Phosphorylation

Concepts & Ideas

Physiology

Co-author Network

Publications

TOP 3
N Zamri; N Masuda; H Nakada; F Oura; Y Yajima; Yoko Fujita-Yamaguchi
Effects of two monoclonal antibodies, MLS128 against Tn-antigen and 1H7 against insulin-like growth factor-I receptor, on the growth of colon cancer cells.
Noriyuki Yuasa; Hideki Asanuma; Tomoyuki Koizumi; Ayano Matsumoto-Takasaki; Hiroshi Nakada; Haruhiko Ogawa; Kazuhiro Tsukamoto; Yoko Fujita-Yamaguchi
Construction and expression of anti-Tn-antigen-specific single-chain antibody genes from hybridoma producing MLS128 monoclonal antibody.
Ganesh P Subedi; Noriyuki Yuasa; Yoko Fujita-Yamaguchi; Shinya Hanashima; Akemi Ikeda; Mamoru Mizuno; Hiroshi Nakada; Reiko Sato; Tadashi Satoh; Yoshiki Yamaguchi
Overproduction of anti-Tn antibody MLS128 single-chain Fv fragment in Escherichia coli cytoplasm using a novel pCold-PDI vector.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yoko Fujita-Yamaguchi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: N Zamri; N Masuda; H Nakada; F Oura; Y Yajima; Yoko Fujita-Yamaguchi
Effects of two monoclonal antibodies, MLS128 against Tn-antigen and 1H7 against insulin-like growth factor-I receptor, on the growth of colon cancer cells.
Bioscience trends 2012;6(6):303-12.
2012: Noriyuki Yuasa; Hideki Asanuma; Tomoyuki Koizumi; Ayano Matsumoto-Takasaki; Hiroshi Nakada; Haruhiko Ogawa; Kazuhiro Tsukamoto; Yoko Fujita-Yamaguchi
Construction and expression of anti-Tn-antigen-specific single-chain antibody genes from hybridoma producing MLS128 monoclonal antibody.
Journal of biochemistry 2012;151(4):371-81.
2012: Ganesh P Subedi; Noriyuki Yuasa; Yoko Fujita-Yamaguchi; Shinya Hanashima; Akemi Ikeda; Mamoru Mizuno; Hiroshi Nakada; Reiko Sato; Tadashi Satoh; Yoshiki Yamaguchi
Overproduction of anti-Tn antibody MLS128 single-chain Fv fragment in Escherichia coli cytoplasm using a novel pCold-PDI vector.
Protein expression and purification 2012;82(1):197-204.
2012: Ayano Matsumoto-Takasaki; Mamoru Mizuno; Hiroshi Nakada; Haruhiko Ogawa; Reiko Sato; Yoshiki Yamaguchi; Noriyuki Yuasa; Ami Aoki; Shinya Hanashima; Hiroko Kawakami; Yoko Fujita-Yamaguchi
Surface plasmon resonance and NMR analyses of anti Tn-antigen MLS128 monoclonal antibody binding to two or three consecutive Tn-antigen clusters.
Journal of biochemistry 2012;151(3):273-82.
2011: Yoko Fujita-Yamaguchi; Ren-Jang Lin; Richard Jove
"US-JAPAN CONFERENCE: INFLAMMATION, DIABETES AND CANCER" held at the Beckman Research Institute of City of Hope, Duarte, CA, USA.
Bioscience trends 2011;5(6):277-80.
2011: Ayano Matsumoto-Takasaki; Hiroshi Nakada; Munehiro Nakata; Sheryl Phung; Keiko Sakai; Noriyuki Yuasa; Normaiza Zamri; Shiuan Chen; Daiichi Katagiri; Tsubasa Koyama; Yoko Fujita-Yamaguchi
Characterization of three different single chain antibodies recognizing non-reducing terminal mannose residues expressed in Escherichia coli by an inducible T7 expression system.
Journal of biochemistry 2011;150(4):439-50.
2011: Yu Kusada; Yoko Fujita-Yamaguchi
Affinity of anti-insulin-like growth factor Ι receptor antibody binding to the receptor altered by plant lectins.
Bioscience trends 2011;5(3):93-8.
2011: K Sakai; T Kurokawa; Y Furui; Y Kuronuma; M Sekiguchi; J Ando; Y Inagaki; W Tang; Munehiro Nakata; Yoko Fujita-Yamaguchi
Invasion of carcinoma cells into reconstituted type I collagen gels: visual real-time analysis by time-lapse microscopy.
Bioscience trends 2011;5(1):10-6.
2010: Tomoyuki Koizumi; Ayano Matsumoto-Takasaki; Hiroshi Nakada; Munehiro Nakata; Yoko Fujita-Yamaguchi
Preparation of asialo-agalacto-glycophorin A for screening of anti-Tn antibodies.
Bioscience trends 2010;4(6):308-11.
2010: Noriyuki Yuasa; Wei Zhang; Tomohiro Goto; Hiroyuki Sakaue; Ayano Matsumoto-Takasaki; Miyo Kimura; Hiroya Ohshima; Yasunobu Tsuchida; Tomoyuki Koizumi; Keiko Sakai; Takumi Kojima; Kazuo Yamamoto; Munehiro Nakata; Yoko Fujita-Yamaguchi
Production of anti-carbohydrate antibodies by phage display technologies: potential impairment of cell growth as a result of endogenous expression.
The Journal of biological chemistry 2010;285(40):30587-97.
2010: Keiko Sakai; Noriyuki Yuasa; Kazuhiro Tsukamoto; Ayano Takasaki-Matsumoto; Yukiko Yajima; Reiko Sato; Hiroko Kawakami; Mamoru Mizuno; Atsushi Takayanagi; Nobuyoshi Shimizu; Munehiro Nakata; Yoko Fujita-Yamaguchi
Isolation and characterization of antibodies against three consecutive Tn-antigen clusters from a phage library displaying human single-chain variable fragments.
Journal of biochemistry 2010;147(6):809-17.
2009: Masahiro Ohtani; Maki Numazaki; Yukiko Yajima; Yoko Fujita-Yamaguchi
Mechanisms of antibody-mediated insulin-like growth factor I receptor (IGF-IR) down-regulation in MCF-7 breast cancer cells.
Bioscience trends 2009;3(4):131-8.
2009: Ayano Matsumoto-Takasaki; Jinichiro Horie; Keiko Sakai; Yoshihiro Furui; Reiko Sato; Hiroko Kawakami; Kazunori Toma; Atsushi Takayanagi; Nobuyoshi Shimizu; Yoko Fujita-Yamaguchi
Isolation and characterization of anti-T-antigen single chain antibodies from a phage library.
Bioscience trends 2009;3(3):87-95.
2009: Noriyuki Morita; Yukiko Yajima; Hideki Asanuma; Hiroshi Nakada; Yoko Fujita-Yamaguchi
Inhibition of cancer cell growth by anti-Tn monoclonal antibody MLS128.
Bioscience trends 2009;3(1):32-7.
2008: Yu Kusada; T Morizono; K Sakai; N Shimizu; A Takayanagi; Yoko Fujita-Yamaguchi
Production of a human antibody fragment against the insulin-like growth factor І receptor as a fusion protein.
Drug discoveries & therapeutics 2008;2(4):245-53.
2008: Hideki Asanuma; Ayano Matsumoto-Takasaki; Yujiro Suzuki; Shin-Ichi Tamura; Tetsutaro Sata; Yu Kusada; Misao Matsushita; Yoko Fujita-Yamaguchi
Influenza PR8 HA-specific Fab fragments produced by phage display methods.
Biochemical and biophysical research communications 2008;366(2):445-9.
2008: Yu Kusada; Toru Morizono; Ayano Matsumoto-Takasaki; Keiko Sakai; Shuma Sato; Hideki Asanuma; Atsushi Takayanagi; Yoko Fujita-Yamaguchi
Construction and characterization of single-chain antibodies against human insulin-like growth factor-I receptor from hybridomas producing 1H7 or 3B7 monoclonal antibody.
Journal of biochemistry 2008;143(1):9-19.
2007: Yu Kusada; Yoko Fujita-Yamaguchi
An overview of currently available anti-insulin-like growth factor I receptor antibodies.
Bioscience trends 2007;1(3):128-33.
2007: Noriyuki Yuasa; Noriko Iida; Hiroyuki Sakaue; Wei Zhang; Sharon Wilczynski; Yoko Fujita-Yamaguchi
Construction of a recombinant single chain antibody recognizing nonreducing terminal mannose residues applicable to immunohistochemistry.
Bioscience trends 2007;1(2):108-12.
2007: Hideki Asanuma; Kohtaro Fujihashi; Takashi Miyakoshi; Tomoki Yoshikawa; Yoko Fujita-Yamaguchi; Naoya Kojima; Munehiro Nakata; Yujiro Suzuki; Shin-Ichi Tamura; Takeshi Kurata; Tetsutaro Sata
Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine.
Vaccine 2007;25(39-40):6975-80.
2007: Wei Zhang; Ayano Matsumoto-Takasaki; Yu Kusada; Hiroyuki Sakaue; Keiko Sakai; Munehiro Nakata; Yoko Fujita-Yamaguchi
Isolation and characterization of phage-displayed single chain antibodies recognizing nonreducing terminal mannose residues. 2. Expression, purification, and characterization of recombinant single chain antibodies.
Biochemistry 2007;46(1):263-70.
2007: Keiko Sakai; Yoshitaka Shimizu; Tomoki Chiba; Ayano Matsumoto-Takasaki; Yu Kusada; Wei Zhang; Munehiro Nakata; Naoya Kojima; Kazunori Toma; Atsushi Takayanagi; Nobuyoshi Shimizu; Yoko Fujita-Yamaguchi
Isolation and characterization of phage-displayed single chain antibodies recognizing nonreducing terminal mannose residues. 1. A new strategy for generation of anti-carbohydrate antibodies.
Biochemistry 2007;46(1):253-62.
2006: Deepali Sachdev; Rajeeva Singh; Yoko Fujita-Yamaguchi; Douglas Yee
Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: implications for anti-insulin-like growth factor therapy in breast cancer.
Cancer research 2006;66(4):2391-402.
2005: Qian Guo; Wei Tang; Norihiro Kokudo; Yasuhiko Sugawara; Kenji Miki; Hirona Karako; Xianjun Qu; Munehiro Nakata; Yoko Fujita-Yamaguchi; Makuuchi Masatoshi
Epidermal growth factor-mediated growth control of confluent mammary epithelial cells cultured on artificial basement membrane.
International journal of molecular medicine 2005;16(3):395-9.
2003: Jing-Jing Ye; Shu-Jian Liang; Ning Guo; Shu-Lian Li; Anna M Wu; S Giannini; Deepali Sachdev; Douglas Yee; N Brünner; David Ikle; Yoko Fujita-Yamaguchi
Combined effects of tamoxifen and a chimeric humanized single chain antibody against the type I IGF receptor on breast tumor growth in vivo.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2003;35(11-12):836-42.
2003: Haruhiko Osawa; Toshiyuki Niiya; Hiroshi Onuma; Akiko Murakami; Masaaki Ochi; Tatsuya Nishimiya; Takahiro Ogura; Kenichi Kato; Ikki Shimizu; Yasuhisa Fujii; Jun Ohashi; Kazuya Yamada; Shu-Jian Liang; Vincent C Manganiello; Yoko Fujita-Yamaguchi; Hideichi Makino
Systematic search for single nucleotide polymorphisms in the 5' flanking region of the human phosphodiesterase 3B gene: absence of evidence for major effects of identified polymorphisms on susceptibility to Japanese type 2 diabetes.
Molecular genetics and metabolism 2003;79(1):43-51.
2003: Deepali Sachdev; Shu-Lian Li; Julie S Hartell; Yoko Fujita-Yamaguchi; Jeffrey S Miller; Douglas Yee
A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Cancer research 2003;63(3):627-35.
2003: Ning Guo; Jing-Jing Ye; Shu-Jian Liang; Rossana Mineo; Shu-Lian Li; Stefano Giannini; Stephen R Plymate; Robert A Sikes; Yoko Fujita-Yamaguchi
The role of insulin-like growth factor-II in cancer growth and progression evidenced by the use of ribozymes and prostate cancer progression models.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2003;13(1):44-53.
2000: Shu-Lian Li; Shu-Jian Liang; Ning Guo; Anna M Wu; Yoko Fujita-Yamaguchi
Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth.
Cancer immunology, immunotherapy : CII 2000;49(4-5):243-52.
2000: epifanio fichera; S Liang; Z Xu; Ning Guo; Rossana Mineo; Yoko Fujita-Yamaguchi
A quantitative reverse transcription and polymerase chain reaction assay for human IGF-II allows direct comparison of IGF-II mRNA levels in cancerous breast, bladder, and prostate tissues.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2000;10(2):61-70.
2000: Rossana Mineo; epifanio fichera; Shu-Jian Liang; Yoko Fujita-Yamaguchi
Promoter usage for insulin-like growth factor-II in cancerous and benign human breast, prostate, and bladder tissues, and confirmation of a 10th exon.
Biochemical and biophysical research communications 2000;268(3):886-92.
2000: J Kasuya; Shu-Jian Liang; H Goko; S H Park; Kenichi Kato; ZD Xu; Steven Hockman; Vincent C Manganiello; Yoko Fujita-Yamaguchi
Cardiac type cGMP-inhibited phosphodiesterase (PDE3A) gene structure: similarity and difference to adipocyte type PDE3B gene.
Biochemical and biophysical research communications 2000;268(3):827-34.
1999: Giuseppe Pandini; Riccardo Vigneri; Angela Costantino; Francesco Frasca; Antonio M Ippolito; Yoko Fujita-Yamaguchi; Kenneth Siddle; Ira D Goldfine; Antonino Belfiore
Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(7):1935-44.
1999: ZD Xu; L Oey; S Mohan; Mark H Kawachi; Nan Sook Lee; John J Rossi; Yoko Fujita-Yamaguchi
Hammerhead ribozyme-mediated cleavage of the human insulin-like growth factor-II ribonucleic acid in vitro and in prostate cancer cells.
Endocrinology 1999;140(5):2134-44.
1998: T Nagaoka; T Shirakawa; Thomas Balon; J C Russell; Yoko Fujita-Yamaguchi
Cyclic nucleotide phosphodiesterase 3 expression in vivo: evidence for tissue-specific expression of phosphodiesterase 3A or 3B mRNA and activity in the aorta and adipose tissue of atherosclerosis-prone insulin-resistant rats.
Diabetes 1998;47(7):1135-44.
1998: Shu-Lian Li; H Goko; ZD Xu; G Kimura; Y Sun; Mark H Kawachi; Timothy G Wilson; S Wilczynski; Yoko Fujita-Yamaguchi
Expression of insulin-like growth factor (IGF)-II in human prostate, breast, bladder, and paraganglioma tumors.
Cell and tissue research 1998;291(3):469-79.
1998: S Li; John Termini; A Hayward; Kenneth Siddle; Y Zick; AP Koval; Derek LeRoith; Yoko Fujita-Yamaguchi
The carboxyl-terminal domain of insulin-like growth factor-I receptor interacts with the insulin receptor and activates its protein tyrosine kinase.
FEBS letters 1998;421(1):45-9.
1998: T Nagaoka; T Shirakawa; J Kasuya; Thomas Balon; Vincent C Manganiello; Yoko Fujita-Yamaguchi
Cyclic nucleotide PDE-3. Quantitation of PDE-3A and -3B mRNAs in rat tissues by RNase protection assay.
Cell biochemistry and biophysics 1998;29(1-2):49-66.
1996: G Kimura; J Kasuya; S Giannini; Y Honda; S Mohan; Mark H Kawachi; M Akimoto; Yoko Fujita-Yamaguchi
Insulin-like growth factor (IGF) system components in human prostatic cancer cell-lines: LNCaP, DU145, and PC-3 cells.
International journal of urology : official journal of the Japanese Urological Association 1996;3(1):39-46.
1995: R Hashimoto; H Fujiwara; N Higashihashi; T Enjoh-Kimura; H Terasawa; Yoko Fujita-Yamaguchi; Fuyuhiko Inagaki; J F Perdue; K Sakano
N-terminal deletion mutants of insulin-like growth factor-II (IGF-II) show Thr7 and Leu8 important for binding to insulin and IGF-I receptors and Leu8 critical for all IGF-II functions.
The Journal of biological chemistry 1995;270(30):18013-8.
1995: J Kasuya; H Goko; Yoko Fujita-Yamaguchi
Multiple transcripts for the human cardiac form of the cGMP-inhibited cAMP phosphodiesterase.
The Journal of biological chemistry 1995;270(24):14305-12.
1994: J Kasuya; S L Li; S Orr; K Siddle; Yoko Fujita-Yamaguchi
The purified COOH-terminal domain of the insulin receptor carries activity to stimulate protein kinase activity or autophosphorylation of the beta subunit domain of insulin receptor.
Biochemical and biophysical research communications 1994;200(2):777-83.
1993: J Kasuya; I Benjamin Paz; B A Maddux; I D Goldfine; S A Hefta; Yoko Fujita-Yamaguchi
Characterization of human placental insulin-like growth factor-I/insulin hybrid receptors by protein microsequencing and purification.
Biochemistry 1993;32(49):13531-6.
1993: P F Yan; S L Li; S J Liang; S Giannini; Yoko Fujita-Yamaguchi
The role of COOH-terminal and acidic domains in the activity and stability of human insulin receptor protein tyrosine kinase studied by purified deletion mutants of the beta subunit domain.
The Journal of biological chemistry 1993;268(30):22444-9.
1993: S L Li; J Kato; I Benjamin Paz; J Kasuya; Yoko Fujita-Yamaguchi
Two new monoclonal antibodies against the alpha subunit of the human insulin-like growth factor-I receptor.
Biochemical and biophysical research communications 1993;196(1):92-8.
1993: Vincenzo Papa; B Gliozzo; G M Clark; W L McGuire; D Moore; Yoko Fujita-Yamaguchi; Riccardo Vigneri; Ira D Goldfine; Vincenzo Pezzino
Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer.
Cancer research 1993;53(16):3736-40.
1993: S L Li; Yoshihiko Miyata; I Yahara; Yoko Fujita-Yamaguchi
Insulin-induced circular membrane ruffling on rat 1 cells expressing a high number of human insulin receptors: circular ruffles caused by rapid actin reorganization exhibit high density of insulin receptors and phosphotyrosines.
Experimental cell research 1993;205(2):353-60.
1992: S L Li; P F Yan; I Benjamin Paz; Yoko Fujita-Yamaguchi
Human insulin receptor beta-subunit transmembrane/cytoplasmic domain expressed in a baculovirus expression system: purification, characterization, and polylysine effects on the protein tyrosine kinase activity.
Biochemistry 1992;31(49):12455-62.
1992: L Xiong; J Kasuya; S L Li; J Kato; Yoko Fujita-Yamaguchi
Growth-stimulatory monoclonal antibodies against human insulin-like growth factor I receptor.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(12):5356-60.
1992: T R LeBon; J Kasuya; R J Paxton; P Belfrage; S Hockman; Vincent C Manganiello; Yoko Fujita-Yamaguchi
Purification and characterization of guanosine 3',5'-monophosphate-inhibited low K(m) adenosine 3',5'-monophosphate phosphodiesterase from human placental cytosolic fractions.
Endocrinology 1992;130(6):3265-74.
1991: Q Y Xu; S L Li; T R LeBon; Yoko Fujita-Yamaguchi
Aggregation of IGF-I receptors or insulin receptors and activation of their kinase activity are simultaneously caused by the presence of polycations or K-ras basic peptides.
Biochemistry 1991;30(51):11811-9.
1991: J F Perdue; T R LeBon; J Kato; Brian Hampton; Yoko Fujita-Yamaguchi
Binding specificities and transducing function of the different molecular weight forms of insulin-like growth factor-II (IGF-II) on IGF-I receptors.
Endocrinology 1991;129(6):3101-8.
1991: K Sakano; T Enjoh; F Numata; H Fujiwara; Y Marumoto; N Higashihashi; Y Sato; J F Perdue; Yoko Fujita-Yamaguchi
The design, expression, and characterization of human insulin-like growth factor II (IGF-II) mutants specific for either the IGF-II/cation-independent mannose 6-phosphate receptor or IGF-I receptor.
The Journal of biological chemistry 1991;266(31):20626-35.
1991: Vincenzo Pezzino; Giovanni Milazzo; Lucia Frittitta; Riccardo Vigneri; O Ezaki; M Kasahara; T R LeBon; Ira D Goldfine; Yoko Fujita-Yamaguchi
Radioimmunoassay for human insulin-like growth factor-I receptor: applicability to breast carcinoma specimens and cell lines.
Metabolism: clinical and experimental 1991;40(8):861-5.
1991: Guenther Boden; F Jadali; L Tappy; Yoko Fujita-Yamaguchi
A radioimmunoassay for human insulin receptor correlation between insulin binding and receptor mass.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1991;23(3):117-21.
1991: DINKAR SAHAL; S L Li; Yoko Fujita-Yamaguchi
Solid-phase protein-tyrosine kinase assay.
Methods in enzymology 1991;200():90-8.
1990: Q Y Xu; R J Paxton; Yoko Fujita-Yamaguchi
Substructural analysis of the insulin receptor by microsequence analyses of limited tryptic fragments isolated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis in the absence or presence of dithiothreitol.
The Journal of biological chemistry 1990;265(30):18673-81.
1990: Yoko Fujita-Yamaguchi
[Insulin-sensitive cAMP phosphodiesterases].
Seikagaku. The Journal of Japanese Biochemical Society 1990;62(9):1162-6.
1990: L M Xiong; T R LeBon; Yoko Fujita-Yamaguchi
Characterization of human placental cytosolic adenosine 3',5'-monophosphate phosphodiesterase by inhibitors and insulin treatment.
Endocrinology 1990;126(4):2102-9.
1989: Yoko Fujita-Yamaguchi; D B Sacks; J M McDonald; DINKAR SAHAL; S Kathuria
Effect of basic polycations and proteins on purified insulin receptor. Insulin-independent activation of the receptor tyrosine-specific protein kinase by poly(L-lysine).
The Biochemical journal 1989;263(3):813-22.
1989: DINKAR SAHAL; Yoko Fujita-Yamaguchi
Solid-phase tyrosine-specific protein kinase assay in multiwell substrate-immobilized polyacrylamide gel.
Analytical biochemistry 1989;182(1):37-43.
1989: Yoko Fujita-Yamaguchi; S Kathuria; Q Y Xu; J M McDonald; H Nakano; T Kamata
In vitro tyrosine phosphorylation studies on RAS proteins and calmodulin suggest that polylysine-like basic peptides or domains may be involved in interactions between insulin receptor kinase and its substrate.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(19):7306-10.
1989: Yoko Fujita-Yamaguchi; J T Harmon; S Kathuria
Radiation inactivation experiments predict that a large aggregate form of the insulin receptor is a highly active tyrosine-specific protein kinase.
Biochemistry 1989;28(11):4556-63.
1989: R Shimoyama; Yoko Fujita-Yamaguchi; Guenther Boden
Anti-insulin receptor antibodies in human diabetes.
Diabetes research and clinical practice 1989;7 Suppl 1():S59-66.
1988: Yoko Fujita-Yamaguchi; S Kathuria
Characterization of receptor tyrosine-specific protein kinases by the use of inhibitors. Staurosporine is a 100-times more potent inhibitor of insulin receptor than IGF-I receptor.
Biochemical and biophysical research communications 1988;157(3):955-62.
1988: L Tappy; Yoko Fujita-Yamaguchi; T R LeBon; Guenther Boden
Antibodies to insulin-like growth factor I receptors in diabetes and other disorders.
Diabetes 1988;37(12):1708-14.
1988: C C Wang; I D Goldfine; Yoko Fujita-Yamaguchi; HG Gattner; D Brandenburg; Pierre De Meyts
Negative and positive site-site interactions, and their modulation by pH, insulin analogs, and monoclonal antibodies, are preserved in the purified insulin receptor.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(22):8400-4.
1988: Guenther Boden; Yoko Fujita-Yamaguchi; R Shimoyama; J J Shelmet; L Tappy; Iraj Rezvani; O E Owen
Nonbinding inhibitory antiinsulin receptor antibodies. A new type of autoantibodies in human diabetes.
The Journal of clinical investigation 1988;81(6):1971-8.
1988: Yoko Fujita-Yamaguchi; J T Harmon
A monomer-dimer model explains the results of radiation inactivation: binding characteristics of insulin receptor purified from human placenta.
Biochemistry 1988;27(9):3252-60.
1988: DINKAR SAHAL; J Ramachandran; Yoko Fujita-Yamaguchi
Specificity of tyrosine protein kinases of the structurally related receptors for insulin and insulin-like growth factor I: Tyr-containing synthetic polymers as specific inhibitors or substrates.
Archives of biochemistry and biophysics 1988;260(1):416-26.
1987: DINKAR SAHAL; Yoko Fujita-Yamaguchi
Protein kinase assay by paper-trichloroacetic acid method: high performance using phosphocellulose paper and washing an ensemble of samples on flat sheets.
Analytical biochemistry 1987;167(1):23-30.
1987: T Kamata; S Kathuria; Yoko Fujita-Yamaguchi
Insulin stimulates the phosphorylation level of v-Ha-ras protein in membrane fraction.
Biochemical and biophysical research communications 1987;144(1):19-25.
1987: Yoko Fujita-Yamaguchi; D H Hawke; John E Shively; S Choi
Partial amino acid sequence analyses of human placental insulin receptor.
Protein sequences & data analysis 1987;1(1):3-6.
1986: Yoko Fujita-Yamaguchi; T R LeBon; M Tsubokawa; W Henzel; S Kathuria; D Koyal; J Ramachandran
Comparison of insulin-like growth factor I receptor and insulin receptor purified from human placental membranes.
The Journal of biological chemistry 1986;261(35):16727-31.
1986: S Kathuria; S Hartman; C Grunfeld; J Ramachandran; Yoko Fujita-Yamaguchi
Differential sensitivity of two functions of the insulin receptor to the associated proteolysis: kinase action and hormone binding.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(22):8570-4.
1986: T R LeBon; S Jacobs; P Cuatrecasas; S Kathuria; Yoko Fujita-Yamaguchi
Purification of insulin-like growth factor I receptor from human placental membranes.
The Journal of biological chemistry 1986;261(17):7685-9.
1986: O Ezaki; M Kasuga; Y Akanuma; K Takata; H Hirano; Yoko Fujita-Yamaguchi; M Kasahara
Recycling of the glucose transporter, the insulin receptor, and insulin in rat adipocytes. Effect of acidtropic agents.
The Journal of biological chemistry 1986;261(7):3295-305.
1985: Yoko Fujita-Yamaguchi; S Kathuria
The monomeric alpha beta form of the insulin receptor exhibits much higher insulin-dependent tyrosine-specific protein kinase activity than the intact alpha 2 beta 2 form of the receptor.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(18):6095-9.
1985: Yoko Fujita-Yamaguchi; Y Sato; S Kathuria
Removal of sialic acids from the purified insulin receptor results in enhanced insulin-binding and kinase activities.
Biochemical and biophysical research communications 1985;129(3):739-45.
1985: T Kadowaki; Yoko Fujita-Yamaguchi; E Nishida; F Takaku; T Akiyama; S Kathuria; Y Akanuma; M Kasuga
Phosphorylation of tubulin and microtubule-associated proteins by the purified insulin receptor kinase.
The Journal of biological chemistry 1985;260(7):4016-20.
1985: T Kadowaki; E Nishida; M Kasuga; T Akiyama; F Takaku; M Ishikawa; H Sakai; S Kathuria; Yoko Fujita-Yamaguchi
Phosphorylation of fodrin (nonerythroid spectrin) by the purified insulin receptor kinase.
Biochemical and biophysical research communications 1985;127(2):493-500.